| 1. |
郎景和. 子宫内膜异位症研究的任务与展望(之一)[J]. 中华妇产科杂志, 2006, 41(5): 289-290.
|
| 2. |
Kettel LM, Murphy AA, Mortola JF, et al. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis[J]. Fertil Steril, 1991, 56(3): 402-407.
|
| 3. |
张曦, 王鑫, 王红静, 等. 大鼠子宫内膜异位症模型建立方法的探索[J]. 华西医学, 2007, 22(4): 831-833.
|
| 4. |
刘万里, 薛茜, 曹明芹, 等. 用SPSS实现完全随机设计多组比较秩和检验的多重比较[J]. 地方病通报, 2007, 22(2): 27-29.
|
| 5. |
Melin A, Sparén P, Persson I, et al. Endometriosis and the risk of Cancer with special emphasis on ovarian Cancer[J]. Hum Reprod, 2006, 21(5): 1237-1242.
|
| 6. |
邬巧霞. 腹腔镜手术联合米非司酮治疗子宫内膜异位症的临床研究[J]. 中国妇幼保健, 2010, 25(23): 3355-3356.
|
| 7. |
周夏伶, 许剑利, 乔林, 等. 米非司酮治疗子宫内膜异位症临床效果观察[J]. 中国计划生育学杂志, 2009, 159(1): 36-38.
|
| 8. |
Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis[J]. Ann N Y Acad Sci, 2002, 955: 159-173.
|
| 9. |
Li X, Bao Y, Fang P, et al. Effect of mifepristone on COX-2 both in eutopic and ectopic endometrium in mouse endometriotic model[J]. Arch Gynecol Obstet, 2012, 286(4): 939-946.
|
| 10. |
Di Carlo A. Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma[J]. Oncol Rep, 2012, 28(3): 1051-1056.
|
| 11. |
Reis ST, Leite KR, Piovesan LF, et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer[J]. BMC Urol, 2012, 12: 18.
|
| 12. |
Nap AW, Dunselman GA, de Goeij AF, et al. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model[J]. Hum Reprod, 2004, 19(10): 2180-2187.
|
| 13. |
Hofmann UB, Westphal JR, Van Kraats AA, et al. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo[J]. Int J Cancer, 2000, 87(1): 12-19.
|
| 14. |
Sillem M, Prifti S, Koch A, et al. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2001, 95(2): 167-174.
|
| 15. |
蔡蕾, 袁卿, 龙雯晴, 等. 米非司酮治疗后MMP-9和TIMP-1在异位和在位子宫内膜中的表达[J]. 上海交通大学学报·医学版, 2007, 27(8): 981-983.
|
| 16. |
Papp C, Schatz F, Krikun G, et al. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium[J]. Early Pregnancy, 2000, 4(4): 230-239.
|
| 17. |
Newfield RS, Spitz IM, Isacson C, et al. Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia[J]. Clin Endocrinol (Oxf), 2001, 54(3): 399-404.
|
